Archive: 06/06/2017
Standard dosage for one lung cancer treatment may be too high
A new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment.
Jun 6, 2017
Copaiba: Silver bullet or snake oil?
Sales of the essential oil copaiba [koh-pey-buh] are increasing, at least in part, because more than 54 million Americans suffer from some form of arthritis and 23.7 million are limited in their usual activity primarily due ...
Jun 6, 2017